跳至主要内容
临床试验/PACTR201807118168502
PACTR201807118168502已完成未知

Effects of Ginger Powder Supplementation on Glycemic Status and Lipid Profile in Patients with Type 2 Diabetes Mellitus

Faculty of Medicine, Ain Shams University0 个研究点目标入组 80 人开始时间: 2018年6月8日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • Newly diagnosed type 2 diabetes mellitus,
  • Glycated hemoglobin (HbA1c) level < 9%,
  • Body Mass Index (BMI) = 30 kg/ m2.

排除标准

  • Diabetes duration more than 6 months,
  • HbA1c level = 9%,
  • BMI < 30 kg/ m2,
  • Insulin therapy,
  • Any injectable or oral antidiabetic medication other than metformin,
  • Any acute illnesses at baseline or during the study,
  • Consumption of less than 80% of the capsules,
  • Any sensitivity due to ginger consumption reported by the patient or noticed after the outset of the study,
  • Consumption of vitamin, mineral or other nutritional supplements,
  • Consumption of alcohol or narcotic drugs,
  • Pregnancy or lactation,
  • Any thyroid or autoimmune disorder,
  • Ischemic, cardiac or renal diseases,
  • Chronic inflammatory diseases,
  • Peptic ulcer,
  • Regular consumption of ginger or other herbal drugs,
  • Consumption of lipid lowering drugs or oral contraceptive pills.

研究者

相似试验

Effects of Ginger Powder Supplementation on Glycemic... | 临床试验